 SAN DIEGO , April 7, 2022 PRNewswire -- Viracta Therapeutics, Inc. Nasdaq: VIRX, a precision oncology company targeting virus-associated malignancies, today announced that company leadership is scheduled to present at the 21st Annual Needham Virtual Healthcare Conference, on Wednesday, April 13, 2022, at 3:00 p.m. EDT. A webcast of the presentation will be available on the Investors section of the Viracta website under Events and Webcasts at 